Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?

Key Points

• Rocket Lab continues to post operational wins, including new solar cell technology and its 16th Electron launch of 2026.
• Rocket Lab’s business remains strong, with record second-quarter revenue and a record $2.36 billion backlog, even as the stock trades far below its May high.
• Neutron remains the most important catalyst for Rocket Lab, with the company still targeting delivery of the first vehicle to the launch pad in the fourth quarter.

Few stocks have tested investor conviction in 2026 as much as Rocket Lab NASDAQ: RKLB. After hitting new highs at $151 in May, shares have slid back to around $62, down roughly 8% for the year and testing a level that could make or break the bulls' case. Yet even as the share price has struggled, the underlying business keeps posting wins. The latest development speaks directly to one of the biggest challenges facing the entire space industry. The question for investors is whether an improving business, sitting on a badly beaten-down stock, is finally worth a closer look or even a nibble long.

Rocket Lab’s Operations Keep Delivering

Rocket Lab recently unveiled new solar cell technology designed to ease supply-chain constraints that have long bottlenecked satellite production. Space-grade solar cells are a critical component for powering spacecraft, and supply has been notoriously tight across the industry. By advancing its own solar cell manufacturing, Rocket Lab is not just solving a problem for itself; it is strengthening its position as a vertically integrated space company that controls more of its own supply chain than most competitors. The announcement briefly moved the stock and reinforced a theme that has defined the company all year: the operational side of this business keeps firing.

Another sign of operational and mission success came on Sept. 11, when the company completed its 16th Electron launch of 2026, cementing its status as the world's leading small launch provider. Combined with a record backlog and a string of national security contract wins in recent months, the fundamental story is arguably in its best shape yet.

The Chart Still Isn’t Confirming the Story

Here is where investors need to be honest with themselves. However well the business is performing, the chart is not yet cooperating. Rocket Lab is holding near major higher-timeframe support around $60, a level that has so far kept the decline in check. But the stock sits below all of its key moving averages, including its closely watched 200-day simple moving average (SMA). That is the technical signature of a stock in a downtrend, not one that has confirmed a bottom.

For momentum to shift back in the bulls' favor, there is real work to be done. The first meaningful sign of a turn would be a reclaim of the $80 level and the 200-day moving average. Until that happens, the buyers still have something to prove, and the safer read is that the stock is basing rather than breaking out. Holding $60 keeps the setup alive; losing it would open the door to further downward momentum.

Neutron Is Still the Main Event

The disconnect between a thriving business and a sluggish, underperforming stock comes down to one word: Neutron. Rocket Lab's medium-lift reusable rocket is the single most important catalyst in the entire investment case, and the market knows it. Electron has made Rocket Lab the dominant small launch provider. Still, Neutron would open the door to the much larger heavy-lift market, putting the company in direct competition for the large, high-value missions that move the revenue needle most. It is also the vehicle tapped to launch major programs like the company's Flatellite constellation.

Neutron remains targeted for debut later this year, and investors are watching that timeline closely. Every solar cell breakthrough, every Electron launch, and every new contract are encouraging, but they are supporting actors, while Neutron is undoubtedly the absolute headliner. A successful debut could be the catalyst that finally realigns the stock with the strength of the business, while any further slippage in the timeline would likely cap momentum.

The Risk-Reward Is Improving, But the Bottom Isn’t Confirmed

The answer comes down almost entirely to time horizon. Analysts remain firmly constructive, with a Moderate Buy consensus across 23 analysts and an average price target of $108.83, implying more than 75% upside, with the bulls still firmly in control of the ratings.

For long-term believers, an underperforming price near major support, paired with a business that keeps winning work and shipping missions, is a genuinely interesting risk-reward. But the technical picture argues for patience. Momentum still does not favor the bulls, and the valuation remains rich at more than 60 times sales. The most disciplined approach may be to watch how the stock behaves around $60, and to let Neutron, not hope, be the guide.